Genpact Stock Plummets to 52-Week Low at USD 37.77

Genpact has reached a new 52-week low, trading at USD 37.77 as of October 29, 2025. This marks a significant decline for the small-cap company, which operates within the miscellaneous industry and has a market capitalization of USD 7,759 million. Over the past year, Genpact's performance has been notably lower than that of the S&P 500, with a return of just 15.24% compared to the index's 18.33%.
Despite the recent price drop, Genpact maintains a relatively low debt-to-equity ratio of 0.27, indicating a conservative approach to leverage. The company has demonstrated strong management efficiency, reflected in a return on equity of 20.86%. However, its net profit for the first nine months has decreased by 23.05%, highlighting some challenges in profitability.

The stock's price-to-earnings ratio stands at 14.00, and it offers a substantial dividend yield of 150.73%. With a price-to-book ratio of 3.00, Genpact is currently trading at a discount compared to its peers' historical valuations. The recent low may prompt further scrutiny of its financial health and market positioning.